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Abstract
Background—Several epidemiological studies have shown a positive association between adult
height and cancer incidence. The only study conducted among women on mouth and pharynx
cancer risk, however, reported an inverse association. This study aims to investigate the
association between height and the risk of head and neck cancer (HNC) within a large
international consortium of HNC.
Methods—We analyzed pooled individual-level data from 24 case-control studies participating
in the International Head and Neck Cancer Epidemiology Consortium. Odds Ratios (ORs) and
95% Confidence Intervals (CIs) were estimated separately for men and women for associations
between height and HNC risk. Educational level, tobacco smoking, and alcohol consumption were
included in all regression models. Stratified analyses by HNC subsites were performed.
Results—This project included 17,666 cases and 28,198 controls. We found an inverse
association between height and HNC (adjusted OR per 10 cm height =0.91, 95% CI 0.86–0.95 for
men; adjusted OR=0.86, 95% CI 0.79–0.93 for women). In men, the estimated OR did vary by
educational level, smoking status, geographic area, and control source. No differences by subsites
were detected.
Conclusions—Adult height is inversely associated with HNC risk. As height can be considered
a marker of childhood illness and low energy intake, the inverse association is consistent with
prior studies showing that HNC occur more frequently among deprived individuals. Further
studies designed to elucidate the mechanism of such association would be warranted.
BACKGROUND
Head and neck cancer (HNC) is the sixth most common cancer worldwide, with more than
half a million cases and 300,000 deaths in 2008 [1]. These malignancies, the majority of
which are squamous cell carcinomas, include cancers of the oral cavity, oropharynx,
hypopharynx and larynx. Tobacco smoking and alcohol consumption are predominant risk
factors for HNC, although other factors, including passive smoking [2, 3], human
papillomavirus (HPV) infection [4], low body-mass index [5], low levels of recreational
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physical activity [6], poor dietary pattern [7], low socioeconomic status [8] and family
history of cancer [9], affect the risk.
Increasing cancer risk with increasing adult height has been reported for all cancers
combined [10–12], and for several specific cancer sites, such as breast, ovary, prostate,
colon, rectum, testis, malignant melanoma, endometrium, kidney, non-Hodgkin lymphoma
and leukaemia [13–20]. The World Cancer Research Fund reported in 2007 that evidence of
an increasing risk associated with attained adult height was convincing for colorectal and
postmenopausal breast cancer only, while it is probable for pancreatic, ovarian, and
premenopausal breast cancer. Evidence was limited, however, for endometrial cancer [21].
A positive association has also been reported between adult height and cancer mortality [15,
22, 23]. On the other hand, an inverse relation was reported for stomach and oesophagus
cancer in some studies [24, 10, 25–27], and recently also for mouth and pharynx cancer [11].
Based on 1,095 incident cases of mouth and pharynx cancers within the Million Women
cohort Study [11], a risk reduction of 6% per 10 cm increasing adult height was reported.
Additionally, the Emerging Risk Factors Collaboration reported a reduction of 13% per 6.5
cm increasing adult height for oral cancer mortality (95% CI: 5%–21%), based on a pooled
analysis of 632 cancer deaths from a large number of cohort studies [23].
In general, a person’s maximum height is determined by a combination of genetic factors
and environmental exposures both in utero and during childhood and adolescence, so that
height can be considered as a biomarker of the interplay of genetic endowment and early-life
experiences [28, 29]. The extent to which a person can reach his/her genetically determined
height is therefore strongly influenced by living conditions and the family’s and previous
generations’ socioeconomic status (SES) [30]. Besides SES, insulin-like growth factor I
(IGFI) circulating levels are also strongly related with childhood and adolescence skeletal
growth [31], with IGFI being positively associated with cancer risk [32].
The purposes of this study are to examine the association between height and the risk of
HNC in a pooled analysis of case-control studies participating in the International Head and
Neck Cancer Epidemiology (INHANCE) Consortium, and to test this association in HNC
subsites.
MATERIALS AND METHODS
Studies and Participants
We conducted the pooled analysis by using data from independent case-control studies
participating in the INHANCE Consortium. The INHANCE Consortium was established in
2004 and includes 35 head and neck cancer case-control studies (several of which are
multicenter) on 25,478 cases and 37,111 controls (data version 1.5) [33]. Cases included
patients with invasive tumors of the oral cavity, oropharynx, hypopharynx, larynx, oral
cavity or pharynx not otherwise specified or overlapping, as defined previously [34].
Details of the case-control studies and data pooling methods for the INHANCE consortium
have been previously described [34]. Face-to-face interviews are conducted in all studies by
trained personnel, except for the following studies: Boston, Germany-Saarland, MSKCC
Leoncini et al. Page 2
Eur J Epidemiol. Author manuscript; available in PMC 2014 August 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
New York, and Japan (2001–2005), in which subjects completed self-administered
questionnaires. All the studies were performed according to the Declaration of Helsinki and
were approved by the local ethics committees. Written informed consents were obtained
from all study subjects.
Inclusion criteria
All case-control studies in the INHANCE Consortium were eligible for inclusion in the
current analysis only if information on height was available for at least 80% of the subjects.
Additionally, among the eligible studies, subjects were excluded if they were: aged <18;
<120 cm in height; had missing information on age, gender or height; or had missing
information on the site of origin of cancer.
Study variables
Variables were formatted to be consistently classified across studies into standard
categories, including age (<50, 50–59, 60–69, ≥70 years), body-mass index (<18.5
[underweight], 18.5–24.9 [normal weight], 25–29.9 [overweight], ≥30 [obese] kg/m2),
education level (no formal education, less than junior high school, some high school, high-
school graduate, vocational/some college, or college graduate/postgraduate), cigarette
smoking status (never, former, current), years of smoking (<10, 10–19, 20–29, 30–39, ≥40),
number of cigarettes smoked per day (<10, 10–19, 20–29, 30–39, ≥40), alcohol drinking
status (never, former, current), alcohol consumption as number of drinks consumed per day
(<1, 1–2, 3–4, ≥5), geographic area (Europe, North America, Central and South America,
and Asia), source of control subjects (hospital-based versus population-based), cancer
subsite (oral cavity, oropharynx, hypopharynx, and larynx) [34].
Body mass index was calculated as the weight divided by the height squared (weight (kg)/
height (m)2) and categorized into four groups according to World Health Organization
criteria as previously reported [35]. Subjects, who have not attained a high school
graduation, were classified as having low education in the data analysis. A detailed
description on the method used for data pooling on smoking and alcohol across different
studies is provided in a previous paper [34].
Height and weight were self-reported at the time of interview in all studies. All pooled data
were cleaned and checked for internal consistency, and clarifications were requested from
the original investigators when needed.
Statistical analysis
Descriptive analyses were conducted to describe the study population by demographic and
known HNC risk factors. Height was expressed as quartiles of the distribution for the
combined control group of all studies and for each gender respectively (<168, 168–172,
173–178, >178 cm for men; <157, 157–160, 161–165, >165 cm for women).
The associations between HNC risk and height (per 10 cm increase) were assessed by
estimating odds ratios (ORs) and 95% confidence intervals (CIs), using unconditional
logistic regression for each case-control study, adjusted by education level, cigarette
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smoking status, years of smoking, number of cigarettes smoked per day, and alcohol
consumption as number of drinks consumed per day. The pooled effect estimates from all
studies, were estimated with random effect models and presented in a Forest plot. We
quantified inconsistencies across studies and their impact on the analysis by using
Cochrane’s Q and the I2 statistic [36, 37]. An estimate of the between-study variance was
also computed using τ2 statistic [38].
To assess the impact of other potentially confounding factors, we examined the percent
change in the age-adjusted pooled OR with the addition of each factor. Subgroup analyses
were also conducted by geographic area, source of control subjects, cancer subsite, and
selected characteristics at recruitment: age, body-mass index, education level, smoking
status, and alcohol drinking status. Statistical analyses were performed separately for men
and women and were done with Stata software, version 12 (StataCorp. 2011. College
Station, TX: StataCorp LP). All statistical tests were two-sided, and p-values < alpha (0.05)
were considered statistically significant.
RESULTS
Overall, of the 35 studies participating in the INHANCE Consortium (version 1.5 with
25,478 cases and 37,111 controls), 11 were immediately excluded, as 6 did not have data on
height (Baltimore, Beijing, France multicenter [1989–1991], Germany-Heidelberg,
HOTSPOT, and Houston), and 5 did not provide data on height at the time of the analysis
(Buffalo, Iowa, France [1987–1992], Rome, and Sao Paulo). Furthermore, two centers
(Goiania, Sao Paulo) from the Latin America multicenter study, and six centers (Australia,
Aviano, Cuba, Milan, Sudan, Udine) from the International multicenter study were
excluded. Figure 1 shows our selection process and lists excluded case control studies with
reasons for their exclusion.
Of the 24 case-control studies, we also excluded participants with missing data on height,
age, and gender (1,148 cases and 581 controls). The final analysis included 17,666 cases and
28,198 controls. Among the cases, 4,714 were oral cancer, 6,254 were pharyngeal cancer,
1,970 were cancers of the oral cavity or pharynx not otherwise specified, 4,407 were
laryngeal cancer and 321 overlapping. Details of the case-control studies are provided in
Table 1. Nine studies were conducted in Europe, ten in North America, two in Central and
South America, two in Asia, one study was conducted on four continents and coordinated by
the International Agency for Research on Cancer (IARC).
Table 2 reports the characteristics of the study population, which included 34,072 men
(74.3% of the entire population; 13,792 cases and 20,280 controls), and 11,792 women
(25.7%; 3,874 cases and 7,918 controls). Among these participants, both men and women,
cases were more likely than controls to be underweight or normal weight, cigarette smokers,
and alcohol drinkers. Controls had higher education levels than cases.
Table 3 shows the distribution of age and selected risk factors in control subjects according
to gender-specific height quartiles. Both in men and women, the taller group tended to be
younger, to have a higher level of education, and more likely to be current drinkers. Among
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men, taller individuals were less likely to be current smokers, while the reverse was true
among women.
The adjusted ORs for HNC risk per 10 cm increase in height for the 24 studies are shown in
Figure 2. Among men, the pooled OR for height was 0.91 (95% CI: 0.86–0.95). There was
little heterogeneity between the effect sizes, accounting for 18% of the variation in point
estimates by using the statistic I2. The estimate of the heterogeneity variance was 0.002. The
point estimate of the pooled ORs was less than 1.0 for 18 of the 24 studies (sign test,
p<0.05).
Among women, the pooled OR was 0.86 (95% CI: 0.79–0.93), and there was no evidence of
heterogeneity across studies. The point estimate of the pooled ORs was less than 1.0 for 19
of the 24 studies (sign test, p<0.05).
Figure 3 shows the ORs for HNC per 10 cm increase in height, in subgroups defined by
geographic area, control source (hospital-based or population-based), cancer subsite, and
selected characteristics at recruitment. In men, the adjusted ORs varied by education level
(I2= 62.7%; τ2=0.004), smoking status (I2= 68.2%; τ2=0.003), geographic area (I2= 63.3%;
τ2=0.003), and control source (I2= 87.7%; τ2=0.006). The OR was 0.87 (95% CI: 0.82–0.91)
for hospital-based case-control studies and 0.97 (95% CI: 0.91–1.03) for population-based
case-control studies. There was little association between height and HNC risk among men
with at least high-school education, and in American populations. There was no substantial
heterogeneity in the estimated association with height across strata of the variables among
women.
We also examined whether estimates varied by gender. We found that pooled ORs and ORs
in every group considered were consistent and do not differ by gender for the association
between increasing height and HNC risk (data not shown).
DISCUSSION
In this pooled analysis of 24 case-control studies including 13,792 men and 3,874 women
with HNC, we found an inverse association between height and HNC risk. The estimated
association was stronger in women than in men (14% vs. 9% risk reduction for per 10 cm
increase in adult height). Furthermore, the estimated associations were reasonably
homogeneous across studies. Our results are consistent with those from the only previous
investigation on mouth and pharynx cancers from a large prospective female cohort study in
UK, which reported a relative risk of 0.94 (95% CI: 0.82–1.08) per 10 cm increase in height
[11]. Additionally, the Emerging Risk Factors Collaboration recently reported an inverse
association between adult height and oral cancer mortality, based on a large set of pooled
cohort studies [23]. In our study, the inverse association between height and HNC risk was
minimal among American men, and it was weaker in population-based studies than in
hospital-based studies among men (adjusted OR = 0.97 vs. 0.87).
Within ethnic groups within countries, studies have shown that short stature is associated
with poor health status [27]. It is known that people with high SES tend to be taller than
those in lower socioeconomic classes [39, 40]. The key role of environmental factors in
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determining adult height is also evident when considering that mean adult height in
industrialized countries markedly increased during the 20th century [41]. Therefore, since
height can be considered as a marker of early life illness, nutrition and psychosocial stress
[42], it is not surprising that several studies reported an inverse association between adult
height and cardiovascular and respiratory disease risk [26, 43, 44]. The relationship between
height and cancer, however, is conflicting. Some cohort studies conducted in different ethnic
groups [10, 12, 11, 14], reported a positive association between height and overall cancer
incidence. However, for the mouth and pharynx [11] as well as stomach and esophagus,
inverse associations were found [24, 10, 25–27].
The results of our pooled analysis suggests that taller people might be at a lower risk for
HNC and corroborates the knowledge that HNC is more common among socio-
economically deprived people [45, 8]. We cannot exclude the possibility that the observed
inverse association between height and HNC risk is attributable to the unmeasured
confounders of childhood or adolescent nutrition status, which are expected to influence
both adult height and cancer risk. Childhood growth is indeed associated with parental SES
[46, 47], and our pooled estimates are adjusted by adult education status, which is again a
good proxy of parental education/SES [48]. However, we cannot rule out confounding by
childhood nutrition.
In this study the association between height and HNC risk differed by educational level,
especially among men. Those with at least a high school degree are no longer at an increased
risk, which suggests a possible residual confounding due to other unknown variables related
to SES being the underlying factors of the height-HNC association in the overall analysis.
In a Scottish study [26], authors postulated that the inverse association between stature and
stomach cancer was due to Helicobacter pylori, which is associated with suboptimal
childhood growth and is a causal component for gastric cancer [49, 50]. Additionally, the
contribution of the infective component causes of HPV [4] in HNC etiology is not supposed
to influence directly childhood and/or adolescent growth, so that we exclude a priori the
potential for confounding or effect modification by HPV.
In our analysis, the population-based studies among men did not show an inverse association
of height with HNC risk, indicating the possible presence of selection bias with hospital
controls. On the other hand, this modifying effect of control source was not evident among
women. When stratifying on geographic region among men, an effect modification was
found. American studies did not show an inverse association between stature and HNC risk.
Both scenarios might be due to selection bias by education level, as hospital based studies
have lower educational level among men in our pooled analysis (data not shown), while in
North America we observed a higher education level of participants compared with the other
regions (data not shown). Even though the stratified analyses are adjusted by educational
level, some residual confounding might persist.
While the present study has its strengths, including its very large size, its capacity to explore
effect modification by several characteristics and the stratified analyses according to cancer
subsites, it is not without limitations. Firstly, we did not have information on SES or
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education of the parents, and used the adult education of the subjects as a proxy, which
might result in residual confounding. Secondly, we did not have information on diet during
childhood and/or adolescence, which affects the growth thus might be key factors
underlying the observed associations. Thirdly, we did not have information on trunk and leg
length, which represent a more direct height component that some studies related with
cancer outcomes [51]. Fourthly, we could not quantify the amount of information bias of
self-reported height in our study, though we believe that its effect would be modest [52].
Fifthly, residual confounding by tobacco and alcohol cannot be excluded as these key risk
factors for HNC might have been measured with error. Lastly, we could not assess the
influence of birth cohort effect on the association between height and HNC, although we
accounted for that by adjusting for age at diagnosis and showing the effect estimates in each
study.
In conclusion, in the present project of a large pool of case-control studies, taller men and
women experienced a lower risk of HNC, controlling for potential confounding due to
smoking, alcohol, and educational level. As it is thought that associations between height,
birth weight, and cancer risk reflect some causal association with a combination of genetics,
hormonal, nutritional, and other factors [21], we believe that the biological mechanisms
underlying the association between height and HNC warrants further investigation.
A Mendelian Randomization approach has been recently suggested to address the
aforementioned research question [53]. By using the genes that regulate the height as a
proxy of the effect of measured adult height in the association between height and cancer,
we would expect to dissect the true effect of height on HNC, without confounding by
environmental variables.
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Figure 1.
Flow diagram of study selection
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Figure 2. Adjusted odds ratios (ORs) and 95% confidence intervals (CI) per 10 cm increase in
height in relation to head and neck cancer risk, by gender, in 24 INHANCE case control studies
OR adjusted by education level, smoking status, cigarette duration, cigarette intensity,
alcohol intensity.
Italy, Milan (1)=1984–89 and (2)=2006–09; North Carolina, USA (1)=1994–97 and
(2)=2002–06; Seattle, WA, USA (1)=1983–87 and (2)=1992–95; Japan (1)=1988–2000 and
(2)=2001–05
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Figure 3. Adjusted odds ratios (ORs) and 95% confidence intervals (CI) per 10 cm increase in
height according to geographic area, control source, cancer site, and selected characteristics at
recruitment, by gender, in 24 INHANCE case control studies
OR adjusted for education level, smoking status, cigarette duration, cigarette intensity,
alcohol intensity, and study center
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